<DOC>
	<DOC>NCT01440465</DOC>
	<brief_summary>The objective of this study was to evaluate the various parameters involved in the occurrence of nausea / vomiting during the first cycle of chemotherapy for solid tumors or hematologic among a group of chemotherapy-naive patients, despite anti standardized-emetics protocols.</brief_summary>
	<brief_title>Management of Nausea and Vomiting Chemotherapy-induced in Normandy</brief_title>
	<detailed_description />
	<mesh_term>Nausea</mesh_term>
	<mesh_term>Vomiting</mesh_term>
	<criteria>Aged over 18 years With solid tumors or hematologic in first line chemotherapy, administered intravenously, Able to understand the meaning of the questions Having given their written consent to participate in the survey. This does not concern patients who: Do not give their consent for participation Do not speak French Suffer from cognitive deficits Are under therapy Must receive a combination of radiochemotherapy Present an occlusive syndrome Metastases (s) brain (s) clinically symptomatic (s) or radiologically proven (s) or a (of) tumor (s) brain (s) Have been previously treated with chemotherapy Present a consindication to corticosteroids, with antiserotonin or NK1 receptor inhibitors Pregnant or breastfeeding.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>chemotherapy</keyword>
	<keyword>cancer</keyword>
	<keyword>nausea</keyword>
	<keyword>vomiting</keyword>
</DOC>